AgingResearch.NewsJoin free

Adeno-associated virus serotype 9 FNDC5

Adeno-associated virus serotype 9 FNDC5 has been studied in 1 paper since 2022: none in people yet, 1 in animals. The research so far is in animals. The newest paper, Feb 15, 2022: “Fibronectin type III domain-containing 5 improves aging-related cardiac dysfunction in mice”.

Intervention

1 paper studies it1 findingUpdated

C, W, M, H: cells, worms or flies, mice, humans. Dark: independent labs found the same change there. Light: one lab or one study. Outline: nothing yet.

  • 1 lab in 1 country
  • Funders: Fundamental Research Funds for the Central Universities and 2 more
  • Animals1

What did studies of Adeno-associated virus serotype 9 FNDC5 find?

1

Studies of Adeno-associated virus serotype 9 FNDC5 measured 1 outcome; the most studied are cardiac dysfunction (1 study).

Cardiac dysfunction

downin mice1

1 study

  1. Adeno-associated virus serotype 9 FNDC5 decreases cardiac dysfunction in mice.

    “More importantly, FNDC5 gene transfer in early life could delay the onset of cardiac dysfunction during aging process.”

    Animalsduring aging

    Fibronectin type III domain-containing 5 improves aging-related cardiac dysfunction in mice

    Aging cell

Latest

Related